AAESX
Price
$16.21
Change
-$0.04 (-0.25%)
Updated
Nov 13 closing price
PAAQX
Price
$14.62
Change
-$0.03 (-0.20%)
Updated
Nov 13 closing price
Ad is loading...

AAESX vs PAAQX

Header iconAAESX vs PAAQX Comparison
Open Charts AAESX vs PAAQXBanner chart's image
Invesco Select Risk: Growth Investor R6
Price$16.21
Change-$0.04 (-0.25%)
VolumeN/A
CapitalizationN/A
Invesco Active Allocation R6
Price$14.62
Change-$0.03 (-0.20%)
VolumeN/A
CapitalizationN/A
AAESX vs PAAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AAESX vs. PAAQX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAESX is a Buy and PAAQX is a Sell.

FUNDAMENTALS
Fundamentals
PAAQX has more cash in the bank: 1.97B vs. AAESX (1B). PAAQX pays higher dividends than AAESX: PAAQX (1.92) vs AAESX (0.60). AAESX was incepted earlier than PAAQX: AAESX (8 years) vs PAAQX (5 years). AAESX is a more actively managed with annual turnover of: 24.00 vs. PAAQX (21.00). AAESX (1000000) and PAAQX (1000000) have matching initial minimum investment requirements. PAAQX (20.76) and AAESX (20.69) have marching annual gain over last year. PAAQX return over 5 years is better than : 5.34 vs. AAESX (3.98).
AAESXPAAQXAAESX / PAAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years5 years-
Gain YTD12.14612.26199%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1B1.97B51%
Annual Yield % from dividends0.601.9231%
Returns for 1 year20.6920.76100%
Returns for 3 years-7.76-8.6090%
Returns for 5 years3.985.3475%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFLT27.700.33
+1.21%
Confluent
ASMB16.570.16
+0.98%
Assembly Biosciences
TXO19.080.09
+0.47%
TXO Partners LP
ACON0.18-0.01
-3.69%
Aclarion
DEI18.16-0.87
-4.57%
Douglas Emmett